Patricia de Araujo-Souza

Prof. Patricia de Araujo-Souza

Department of Genetics, Universidade Federal do Paraná
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
ASAlana Serrano Campelo de Souza
Alana Serrano Campelo de Souza
LGLetícia Boslooper Gonçalves
Letícia Boslooper Gonçalves
ALAna Paula Lepique
Ana Paula Lepique
PAPatricia de Araujo-Souza
Patricia de Araujo-Souza
The tumor microenvironment (TME) is complex, and its composition and dynamics determine tumor fate. From tumor cells themselves, with their capacity for unlimited replication, migration, and invasion, to fibroblasts, endothelial cells, and immune cells, which can have pro and/or anti-tumor potential, interaction among these elements determines tumor progression. The understanding of molecular pathways involved in immune escape has permitted the development of cancer immunotherapies. Targeting molecules or biological processes that inhibit antitumor immune responses has allowed a significant improvement in cancer patient’s prognosis. Autophagy is a cellular process required to eliminate dysfunctional proteins and organelles, maintaining cellular homeostasis. Usually a process associated with protection against cancer, autophagy associated to cancer cells has been reported in response to hypoxia, nutrient deficiency, and oxidative stress, conditions frequently observed in the TME. Recent studies have shown a paradoxical association between autophagy and tumor immune responses. Tumor cell autophagy increases the expression of inhibitory molecules, such as PD-1 and CTLA-4, which block antitumor cytotoxic responses. Moreover, it can also directly affect antitumor immune responses by, for example, degrading NK cell-derived granzyme B and protecting tumor cells. Interestingly, the activation of autophagy on dendritic cells has the opposite effects, enhancing antigen presentation, triggering CD8+ T cells cytotoxic activity, and reducing tumor growth. Therefore, this review will focus on the most recent aspects of autophagy and tumor immune environment. We describe the dual role of autophagy in modulating tumor immune responses and discuss some aspects that must be considered to improve cancer treatment.

3 December 2020 in Acta Cytologica
Verified
Journal Article
Closed access
PDF file
ALAdhemar Longatto-Filho
Adhemar Longatto-Filho
JFJosé Humberto T.G. Tavares Guerreiro Fregnani
José Humberto T.G. Tavares Guerreiro Fregnani
ACAllini Mafra da Costa
Allini Mafra da Costa
PAPatricia de Araujo-Souza
Patricia de Araujo-Souza
CSCristovam Scapulatempo-Neto
Cristovam Scapulatempo-Neto
LTLara Termini
Lara Termini
Introduction: The main risk factor for the development of cervical cancer (CC) is persistent infection by human papillomavirus (HPV) oncogenic types. In order to persist, HPV exhibits a plethora of immune evasion mechanisms. PI3/Elafin (Peptidase Inhibitor 3) is an endogenous serine protease inhibitor involved in epithelial protection against pathogens. PI3/Elafin’s role in CC is still poorly understood. Materials and Methods: In the present study, we addressed PI3/Elafin protein detection in 123 CC samples by immunohistochemistry and mRNA expression in several datasets available at Gene Expression Omnibus and The Cancer Genome Atlas platforms. Results: We observed that PI3/Elafin is consistently downregulated in CC samples when compared to normal tissue. Most of PI3/Elafin-positive samples exhibited this protein at the plasma membrane. Besides, high PI3/Elafin expression at the cellular membrane was more frequent in in situ stages I + II than in invasive cervical tumor stages III + IV. This indicates that PI3/Elafin expression is gradually lost during the CC progression. Of note, advanced stages of CC were more frequently associated with a more intense PI3/Elafin reaction in the nuclei and cytoplasm. Conclusion: Our results suggest that PI3/Elafin levels and subcellular localization may be used as a biomarker for CC severity.

23 June 2021 in Cells
Verified
Journal Article
Open access
PDF file
ESEsdras Matheus Gomes da Silva
Esdras Matheus Gomes da Silva
LSLetícia Graziela Costa Santos
Letícia Graziela Costa Santos
FOFlávia Santiago de Oliveira
Flávia Santiago de Oliveira
FFFlávia Cristina de Paula Freitas
Flávia Cristina de Paula Freitas
VPVinícius da Silva Coutinho Parreira
Vinícius da Silva Coutinho Parreira
FPFabio Passetti
Fabio Passetti
Alternative splicing (AS) may increase the number of proteoforms produced by a gene. Alzheimer’s disease (AD) is a neurodegenerative disease with well-characterized AS proteoforms. In this study, we used a proteogenomics strategy to build a customized protein sequence database and identify orthologous AS proteoforms between humans and mice on publicly available shotgun proteomics (MS/MS) data of the corpus callosum (CC) and olfactory bulb (OB). Identical proteotypic peptides of six orthologous AS proteoforms were found in both species: PKM1 (gene PKM/Pkm), STXBP1a (gene STXBP1/Stxbp1), Isoform 3 (gene HNRNPK/Hnrnpk), LCRMP-1 (gene CRMP1/Crmp1), SP3 (gene CADM1/Cadm1), and PKCβII (gene PRKCB/Prkcb). These AS variants were also detected at the transcript level by publicly available RNA-Seq data and experimentally validated by RT-qPCR. Additionally, PKM1 and STXBP1a were detected at higher abundances in a publicly available MS/MS dataset of the AD mouse model APP/PS1 than its wild type. These data corroborate other reports, which suggest that PKM1 and STXBP1a AS proteoforms might play a role in amyloid-like aggregate formation. To the best of our knowledge, this report is the first to describe PKM1 and STXBP1a overexpression in the OB of an AD mouse model. We hope that our strategy may be of use in future human neurodegenerative studies using mouse models.

30 September 2022 in Sexually Transmitted Diseases
Verified
Journal Article
Closed access
PAPatricia de Araujo-Souza
Patricia de Araujo-Souza
MEMariam El-Zein
Mariam El-Zein
ABAline Do N. Bolpetti
Aline Do N. Bolpetti
PMPaulo Cesar Maciag
Paulo Cesar Maciag
TRTatiana Rabachini
Tatiana Rabachini
LVLuisa L. Villa
Luisa L. Villa
Background: Human papillomavirus (HPV) infection is a necessary cause for cervical cancer, but a majority of genital HPV infections clear spontaneously. Human leukocyte antigen (HLA) polymorphism influences immune response and genetic susceptibility, and its association with cervical cancer was extensively investigated, but few reports focused on HPV infection. Methods: We performed molecular typing of HLA-A, HLA-B, HLA-DQB1, and HLA-DRB1 genes as well as of HPV in 1226 women enrolled in the Ludwig-McGill cohort study and investigated the influence on cumulative HPV positivity. HPV types were grouped according to Alphapapillomavirus subgenera that exhibit similar tissue tropism and biological behavior concerning cancer risk. The associations between HLA polymorphisms and HPV infections were estimated using unconditional logistic regression analysis adjusted for age and race. Results: HLA-B*08 and HLA-DRB1*15:01 were negatively associated with HPV positivity, and similar effects were observed for HPV subgenus 2 only, which includes HPV16. HLA-DRB1*08:07 was associated with overall HPV infection and subgenus 2 positivity. The haplotypes HLA-B*08-DRB1*03:01-DQB1*02:01 and HLA-DRB1*08:07-DQB1*04:02 were negatively and positively associated with cumulative HPV positivity, respectively. Conclusions: Our data suggest that HLA class I and II polymorphism can influence HPV natural infection.

5 September 2024 in HLA
Verified
Journal Article
Closed access
APAlessandro Pirri
Alessandro Pirri
RSRenata Slowik
Renata Slowik
MBMaria da Graça Bicalho
Maria da Graça Bicalho
PAPatricia de Araujo-Souza
Patricia de Araujo-Souza

21 August 2021 in HLA
Verified
Journal Article
Closed access
PDF file
JTJessica Tavares
Jessica Tavares
NPNatalia A. Petry
Natalia A. Petry
JSJosé Samuel da Silva
José Samuel da Silva
MBMaria da Graça Bicalho
Maria da Graça Bicalho
PAPatricia de Araujo-Souza
Patricia de Araujo-Souza